301188 力诺药包
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.5894.2434.4078.35613.050
总资产报酬率 ROA (%)1.6892.9323.4787.28910.991
投入资产回报率 ROIC (%)1.9163.2703.8138.10712.339

边际利润分析
销售毛利率 (%)26.47019.01017.43822.09325.043
营业利润率 (%)16.2716.6727.69415.44515.790
息税前利润/营业总收入 (%)18.3488.2088.19214.39816.033
净利润/营业总收入 (%)14.6836.1136.95814.19114.038

收益指标分析
经营活动净收益/利润总额(%)91.67084.37677.05585.15992.907
价值变动净收益/利润总额(%)6.85718.51819.25611.2233.693
营业外收支净额/利润总额(%)0.167-0.932-0.109-0.189-0.056

偿债能力分析
流动比率 (X)3.8644.0887.0734.7735.373
速动比率 (X)3.0723.2796.0053.9304.751
资产负债率 (%)35.45334.03227.46112.72912.802
带息债务/全部投入资本 (%)24.40521.00219.9522.0222.385
股东权益/带息债务 (%)296.985359.905394.1364,801.7124,063.183
股东权益/负债合计 (%)182.065193.840264.157685.633681.110
利息保障倍数 (X)8.9505.13716.164-14.14663.534

营运能力分析
应收账款周转天数 (天)74.76065.40862.86864.70851.568
存货周转天数 (天)125.48598.15985.14179.73459.226